Search results for: 'Drug Discovery and Early Development Outsourcing Services'

28 Aug 2020  |  Global  |  Technology Research

Data Science Impacting the Pharmaceutical Industry

Part I: Drug Discovery Applications

Infographics

×

Data science and AI have the potential to transform drug discovery in terms of costs, speed and efficiency. With explosion in biomedical data, data sharing and analysis platforms have surged. AI technologies are moving to the next phase of advancements, and when combined with other emerging tech areas, AI is expected to witness a full fledged adopt...

The scale and sophistication of cyberattacks in China continue to rise, driven by the rapid adoption of cloud computing, mobile applications, IoT devices, and industrial digitalization. Increasing automation of attacks, combined with wider use of AI-driven intrusion techniques, is placing unprecedented pressure on organizations to strengthen visibi...

The customer experience (CX) management services market continues to expand in North America as enterprises accelerate the use of external service providers to improve operational efficiency, augment internal capabilities, and deliver more consistent, omnichannel customer engagement. As economic pressures intensify and consumer expectations rise, g...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision medicine. It highlights AI-driven platforms, advanced biologics, and digital health solutions that address critical challenges in accessibili...

Brands use outsourcing as a competitive strategy to get a multitude of benefits, including cost savings, best-in-class technology, business flexibility, access to skilled talent, and a blend of locations and delivery models. Customer experience (CX) outsourcing vendors partner with clients to understand their business challenges and offer solutions...

More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...

The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward specialized development and manufacturing capabilities ...

This research consists of an analysis of developments in biosensors

India's aerospace engineering services market is evolving from cost-led engineering delivery to higher-value, strategic aerospace engineering participation. The market comprises outsourced engineering services delivered from India by third-party engineering and digital service providers that support commercial aviation, defense aviation, space, and...